Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Dapagliflozin safe, effective in HF patients across global regions
08 Sep 2023
bởiStephen Padilla
Dapagliflozin for individuals with heart failure (HF) demonstrates consistent safety and efficacy across regions worldwide despite geographic differences in patient characteristics, background treatment, and event rates, reports a recent study.
Dapagliflozin safe, effective in HF patients across global regions
08 Sep 2023
Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia
08 Sep 2023
bởiAudrey Abella
In patients admitted to the intensive care unit (ICU) for severe community-acquired pneumonia (CAP), those who received hydrocortisone had a lower mortality risk compared with those on placebo, findings from the CAPE COD* trial suggest.